Alphatec Spine to Showcase New Minimally Invasive (MIS) and Complex Spine Products at the Upcoming 31st Annual North American...
October 18 2016 - 4:15PM
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of
Alphatec Spine, Inc., a provider of spinal fusion technologies,
announced today that it will introduce several new products, as
well as its current comprehensive portfolio at the upcoming North
American Spine Society (NASS) meeting at the Boston Convention and
Exhibition Center in Boston, Massachusetts, which will be held from
October 26th – 29th, 2016. Alphatec Spine will be located in
booth number 1523. In addition, today the Company announced
that it has received 510(k) clearance from the U.S. Food and Drug
Administration (FDA) for its Battalion™ Lateral Spacer System
featuring the Alphatec Squadron™ Lateral Retractor.
“We are excited to demonstrate our newest products
at NASS this year, including our new lateral system, the Battalion
Lateral Spacer System, which features a unique and innovative
retractor that we believe offers surgeons improved functionality
and better patient outcomes,” said Leslie Cross, Chairman and
interim Chief Executive Officer. “Our new XYcor® Expandable
Spinal Spacer System and Arsenal™ Deformity systems will also be
showcased. Each of these new products leverage and complement
our robust Arsenal Spinal Fixation platform - providing
comprehensive and compelling solutions for our surgeon customers
and their patients. With our revitalized product pipeline and
portfolio, we are increasing our market opportunities in the U.S.,
including our new offerings in the MIS and complex spine markets,
two of the fastest growing market segments of spine.”
Alphatec will be showcasing its broad portfolio of
spinal fusion products, including the Company’s newest spinal
fusion products:
Alphatec Spinal Fusion Technologies
Technical Exhibit Booth #1523:
- Battalion Lateral Spacer System and Squadron Lateral
Retractor: The Battalion Lateral Spacer System with
the Alphatec Squadron Lateral Retractor provides surgeons with a
next-generation lateral system with unrivaled, unique design
characteristics - total blade control technology that allows the
surgeon to maintain approach aperture throughout the procedure,
including in-situ blade height adjustment and blade replacement,
combined with the Battalion Lateral Spacer will be available in
0°and 15° lordosis with a variety of width and height options for
lumbar and thoracic approaches.
- XYcor Expandable Spinal Spacer System:
The XYcor system provides surgeons with a minimally invasive
inspired solution for PLIF and TLIF procedures by utilizing a
smaller, more compact ALIF sized implant that can accommodate a
variety of patient pathologies. The system provides nearly five
times the amount of bone graft potential compared to standard PLIF
and TLIF cages.
- Arsenal Deformity Spinal Fixation
System: The Arsenal Deformity System was
thoughtfully designed to provide surgeons with a complete solution
to address complex deformity pathologies. The system features
unique uniplanar and monoaxial screws, providing the surgeon with
easier screw positioning and rod placement through a tulip that has
360 degrees of rotation while restricting motion in the
medial/lateral plane for derotation correction.
Alphatec Workshops and
Presentations:
- “Alphatec Spine Complex Solutions: Avoiding
Pitfalls in Complex Deformity” by Dr. Kirkham Wood and Dr.
Saechin Kim:
- Wednesday, October 26th – 8:00am EDT, The Learning
Place
- “Discover XYcor the New Expandable Spinal Spacer
System” by Dr. Henry F. Fabian, Jr.:
- Wednesday, October 26th – 3:15pm EDT, Alphatec booth #1523
- Thursday, October 27th – 9:45am EDT, Alphatec booth #1523
About Alphatec Spine
Alphatec Spine, Inc., a wholly owned subsidiary of
Alphatec Holdings, Inc., is a provider of spinal fusion
technologies for the treatment of spinal disorders associated with
trauma, congenital deformities, disease and degeneration. The
Company's mission is to combine innovative surgical solutions with
world-class customer service to improve outcomes and patient
quality of life. The Company markets products in the U.S. via a
direct sales force and independent distributors.
Additional information can be found at
www.alphatecspine.com.
About the North American Spine Society
(NASS)
The North American Spine Society is a global
multidisciplinary medical society that utilizes education, research
and advocacy to foster the highest quality, ethical, value- and
evidence-based spine care for patients. The society is
comprised of almost 9,000 members worldwide from disciplines
including orthopedic surgery, neurosurgery, physical medicine and
rehabilitation, pain management, physical/occupational therapy,
anesthesiology, radiology and other health care professionals
focused on the spine.
Additional information can be found at
www.nassannualmeeting.org.
Forward Looking Statements
This press release may contain "forward-looking
statements" within the meaning of the Private Securities Litigation
Reform Act of 1995 that involve risks and uncertainty. Such
statements are based on management's current expectations and are
subject to a number of risks and uncertainties that could cause
actual results to differ materially from those described in the
forward-looking statements. Alphatec Spine cautions investors that
there can be no assurance that actual results or business
conditions will not differ materially from those projected or
suggested in such forward-looking statements as a result of various
factors. Forward-looking statements include references to the
Company's belief that certain of its products offer competitive
functionalities in the marketplace. In addition, forward-looking
statements include the Company's ability to successfully develop
and commercialize its current products and new products, including
the products discussed in this press release. The words "believe,"
"will," "should," "expect," "intend," "estimate" and "anticipate,"
variations of such words and similar expressions identify
forward-looking statements, but their absence does not mean that a
statement is not a forward-looking statement. The important
factors that could cause actual operating results to differ
significantly from those expressed or implied by such
forward-looking statements include, but are not limited to; the
uncertainty of success in developing new products or products
currently in Alphatec Spine's pipeline, including without
limitation the products discussed in this press release; the
uncertainties regarding the ability to successfully license or
acquire new products and the commercial success of such products;
failure to achieve acceptance of Alphatec Spine's products by the
surgeon community, including without limitation the products
discussed in this press release; Alphatec Spine's ability to
develop and expand its U.S. revenues; continuation of favorable
third part payor reimbursement for procedures performed using
Alphatec Spine's products, including the products discussed in this
press release; unanticipated expenses or liabilities or other
adverse events affecting cash flow or Alphatec Spine's ability to
successfully control its costs or achieve profitability;
uncertainty of additional funding; Alphatec Spine's ability to
compete with other competing products and with emerging new
technologies; product liability exposure and patent infringement
claims and claims related to Alphatec Spine's intellectual
property. Please refer to the risks detailed from time to time in
Alphatec Spine's SEC reports, including its Annual Report Form
10-K, as well as other filings on Form 10-Q and periodic filings on
Form 8-K. Alphatec Spine disclaims any intention or
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events, or
otherwise, unless required by law.
CONTACT: Investor/Media Contact:
Christine Zedelmayer
Investor Relations
Alphatec Spine, Inc.
(760) 494-6610
czedelmayer@alphatecspine.com
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From Apr 2023 to Apr 2024